VCYT Q4 2017 Earnings — Veracyte, Inc. Revenue & Financial Results | Market Cap Arena

VCYTVeracyte, Inc.

$3B

Q4 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$20M+7.3% YoY

Gross Profit

$12M60.4% margin

Operating Income

-$6M-30.8% margin

Net Income

-$8M-43.1% margin

EPS (Diluted)

$-0.25

QoQ Revenue Growth

+11.9%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$6M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$79M

Total Liabilities

$41M

Stockholders' Equity

$37M

Cash & Equivalents

$34M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$20M	$18M	+7.3%
Gross Profit	$12M	$12M	+0.7%
Operating Income	-$6M	-$4M	-64.6%
Net Income	-$8M	-$4M	-91.7%